These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8419476)

  • 21. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation.
    Carrasco-Marín E; Alvarez-Domínguez C; Leyva-Cobián F
    Eur J Immunol; 1994 Sep; 24(9):2031-9. PubMed ID: 8088323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition by brefeldin A of the specific B cell antigen presentation to MHC class II-restricted T cells.
    Kakiuchi T; Takatsuki A; Watanabe M; Nariuchi H
    J Immunol; 1991 Nov; 147(10):3289-95. PubMed ID: 1940337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
    Villacres MC; Behboudi S; Nikkila T; Lovgren-Bengtsson K; Morein B
    Cell Immunol; 1998 Apr; 185(1):30-8. PubMed ID: 9636680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gamma radiation on resting B lymphocytes. II. Functional characterization of the antigen-presentation defect.
    Ashwell JD; Jenkins MK; Schwartz RH
    J Immunol; 1988 Oct; 141(8):2536-44. PubMed ID: 2844902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.
    Svensson M; Stockinger B; Wick MJ
    J Immunol; 1997 May; 158(9):4229-36. PubMed ID: 9126984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of MHC class II presentation of particulate antigens of B lymphocytes.
    Vidard L; Kovacsovics-Bankowski M; Kraeft SK; Chen LB; Benacerraf B; Rock KL
    J Immunol; 1996 Apr; 156(8):2809-18. PubMed ID: 8609400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
    Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
    J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors.
    Vidard L; Rock KL; Benacerraf B
    J Immunol; 1991 Sep; 147(6):1786-91. PubMed ID: 1890304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal and adult microglia cross-present exogenous antigens.
    Beauvillain C; Donnou S; Jarry U; Scotet M; Gascan H; Delneste Y; Guermonprez P; Jeannin P; Couez D
    Glia; 2008 Jan; 56(1):69-77. PubMed ID: 17932942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen.
    Volkmann A; Zal T; Stockinger B
    J Immunol; 1997 Jan; 158(2):693-706. PubMed ID: 8992985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
    Grant CF; Ali R; Povey S; Stockinger B
    Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
    Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capacity of antigen uptake by B cells, fibroblasts or macrophages determines efficiency of presentation of a soluble self antigen (C5) to T lymphocytes.
    Stockinger B
    Eur J Immunol; 1992 May; 22(5):1271-8. PubMed ID: 1577067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
    González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
    Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide.
    Kim DT; Mitchell DJ; Brockstedt DG; Fong L; Nolan GP; Fathman CG; Engleman EG; Rothbard JB
    J Immunol; 1997 Aug; 159(4):1666-8. PubMed ID: 9257826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.
    Scheerlinck JP; Burssens G; Brys L; Michel A; Hauser P; De Baetselier P
    Immunology; 1991 May; 73(1):88-94. PubMed ID: 2045130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.
    Chamoto K; Wakita D; Narita Y; Zhang Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Cancer Res; 2006 Feb; 66(3):1809-17. PubMed ID: 16452242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-T cellular interaction between CD4-CD8- regulatory T cells and T cell clones presenting TCR peptide. Its implication for TCR vaccination against experimental autoimmune encephalomyelitis.
    Kozovska MF; Yamamura T; Tabira T
    J Immunol; 1996 Aug; 157(4):1781-90. PubMed ID: 8759768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences among various lineages of antigen-presenting cells in processing exogenous antigen internalized through transferrin receptors.
    McCoy KL; Page MS; Merkel BJ; Inman JK; Stutzman R
    J Immunol; 1993 Dec; 151(12):6757-68. PubMed ID: 7903098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.